tertiary alcohols.8 In this process, a benzylic carbamate
derived from an enantioenriched secondary alcohol is
deprotonated9 and reacted with a boronic ester to give
an intermediate boronate complex; subsequent stereospe-
cific 1,2-metalate rearrangement and oxidation thereafter
lead to highly enantioenriched tertiary alcohols (Scheme 1).
Herein we report the application of this methodology to the
synthesis of R-heterocyclic tertiary alcohols.
Scheme 2. Scope of the LithiationÀBorylation Methodologya
We began our studies by preparation of the required
starting materials; the enantioenriched carbamate 1 was syn-
thesized by enzymatic resolution of racemic phenylethanol10
followed by carbamoylation with N,N-diisopropylcarbamoyl
chloride, giving the carbamate 1 in >99:1 er. The boronic
esters were synthesized by condensation of the appropri-
ate boronic acid with pinacol.
Initial attemptstohomologate 3-pyridylpinacol boronic
ester proved unsuccessful, which we attributed to its poor
solubility in compatible reaction solvents (Et2O, toluene,
hexane, TBME). However, we found that the inclusion of
a halogen substituent on the pyridyl ring greatly aided
solubility. We subjected boronic ester 2a to lithiationÀ
borylation using MgBr2/MeOH as an additive to enhance
er (method A). Pleasingly, the tertiary boronic ester 3a was
formed in 50% yield (Scheme 2). Subsequent oxidation of
3a with NaOH/H2O2 gave the desired tertiary alcohol 4a in
76% yield and 98:2 er. When this was carried out without
isolation of the intermediate tertiary boronic ester, 4a was
isolated in 45% yield and 98:2 er.
Encouraged by this result, we sought to establish the
scope of the lithiationÀborylation method using a range of
commercially available heterocyclic boronic acids11 from
which we could synthesize the corresponding boronic
esters. Continuing the investigation of ortho-substituted
boronic esters, we utilized the 2-fluoro- and 2-methoxy-
substituted pyridyl boronic esters 2b and 2c and isolated
the tertiary boronic esters 3b and 3c in excellent yield.
Oxidation of both tertiary boronic esters3band 3cgavethe
corresponding tertiary alcohols 4b and 4c in high yield and
enantiomeric ratio. The additional ortho-substituents on
the pyridyl ring appear to be well tolerated without detri-
ment to the yield or enantioselectivity of the lithiationÀ
borylation.
a Conditions A: 2 added to Li-1 as a 1 M Et2O or 0.5 M PhMe solu-
tion, subsequent addition of MgBr2/MeOH prior to warming to rt. B: 2
added to Li-1 as a 1 M Et2O or 0.5 M PhMe solution (no MgBr2/MeOH).
Having established that the lithiationÀborylation reac-
tion could be applied to pyridyl boronic esters, we explored
reaction conditions with and without MgBr2/MeOH (con-
ditions A and B respectively). In the case of 2-substituted-
3-boryl pyridines (4aÀc), a higher er and yield were
achieved with the use of MgBr2/MeOH (conditions A),
especially in the case of 4c. This reflects an element of
reversibility in the ate complex formation, arising from the
increased steric hindrance of the ortho-substituted boronic
esters. Upon warming the reaction to room temperature,
the lithiated carbamate so generated becomes configura-
tionally labile and begins to racemize, and subsequent
recombination leads to the tertiary boronic ester with a
reduced er (Scheme 3). In the presence of MgBr2/MeOH,
the extent of reversibility is reduced relative to 1,2-migra-
tion, and any lithiated carbamate that is released is im-
mediately trapped by MeOH, leading to an increased er.
(6) For a rare example of asymmetric addition to pyridyl ketones
using alkyl Grignards, see: (a) Weber, B.; Seebach, D. Tetrahedron 1994,
50, 6117. For examples of asymmetric additions to furyl and thiophene
ketones with organoaluminium and organzinc nucleophiles respectively,
see: (b) Biradar, D. B.; Zhou, S.; Gau, H.-M. Org. Lett. 2009, 11, 3386.
(c) Hatano, M.; Mizuno, T.; Ishihara, K. Tetrahedron 2011, 67, 4417.
(7) (a) Garg, D. C.; Jallad, N. S.; Singh, S.; Ng, K. F.; Weidler, D. J.
J. Clin. Pharmacol. 1988, 28, 812. (b) Matsunaga, N.; Kaku, T.; Ojida, A.;
Tanaka, T.; Hara, T.; Yamaoka, M.; Kusaka, M.; Tasaka, A. Bioorg. Med.
ꢀ ꢀ
Chem. 2004, 12, 4313. (c) Starck, J. P.; Talaga, P.; Quere, L.; Collart, P.;
Christophe, B.; Brutto, P. L.; Jadot, S.; Chimmanamada, D.; Zanda, M.;
Wagner, A.; Mioskowski, C.; Massingham, R.; Guyaux, M. Bioorg. Med.
Chem. Lett. 2006, 16, 373. (d) Beaton, G.; Moree, W. W. J.; Jovic, F.; Coon,
T.; Yu, J. U.S. Patent US2006014797 A1 Jan 19, 2006
(8) (a) Stymiest, J. L.; Bagutski, V.; French, R. M.; Aggarwal, V. K.
Nature 2008, 456, 778. (b) Aggarwal, V. K.; Bagutski, V.; French, R. M.
Angew. Chem., Int. Ed. 2010, 49, 5142.
ꢀ
(9) (a) Hoppe, D.; Carstens, A.; Kramer, T. Angew. Chem., Int. Ed.
1990, 29, 1424. (b) Carstens, A.; Hoppe, D. Tetrahedron 1994, 50, 6097.
(10) Ou, L.; Xu, Y.; Ludwig, D.; Pan, J.; He, Xu, J. Org. Process Res.
Dev. 2008, 12, 192.
(11) Boronic acids were obtained from Inochem-Frontier.
Org. Lett., Vol. 15, No. 6, 2013
1347